Cannabinoids from C. sativa L.: Systematic Review on Potential Pharmacological Effects against Infectious Diseases Downstream and Multidrug-Resistant Pathogens
Open Access
- 9 September 2024
- journal article
- review article
- Published by MDPI AG in Future Pharmacology
- Vol. 4 (3) , 590-625
Abstract
Cannabis sativa L. has garnered attention as a potential source for new antimicrobial agents, particularly due to the increased prevalence of microbial resistance to conventional antimicrobials and the emergence of multidrug-resistant pathogens. This review, conducted according to the PRISMA 2020 statement, systematically analyzed the antimicrobial properties of C. sativa extracts and cannabinoids against various bacteria, fungi, viruses, and parasites. Data were collected from the scientific literature (102 papers) and clinical trials (5 studies) from 2014 to June 2024. Findings revealed that cannabinoids, especially CBD, demonstrate significant antimicrobial activity against Gram-positive bacteria like MRSA, Gram-negative bacteria such as Pseudomonas aeruginosa, various Candida species, SARS-CoV-2, and HIV. Additionally, CBD showed efficacy against parasitic infections like Echinococcus granulosus and Leishmania species. These results suggest that cannabinoids may represent a new class of antimicrobial agents with unique and diverse mechanisms of action, potentially effective in broad-spectrum therapies. This study highlights the urgent need for further research and standardized clinical trials to validate these findings and to develop cannabinoid-based treatments. The antimicrobial properties of C. sativa align with WHO priorities and support global health initiatives, offering promising avenues for addressing antimicrobial resistance and improving public health outcomes.Keywords
Funding Information
- FCT—Foundation for Science and Technology (UID/DTP/04138/2021)
This publication has 112 references indexed in Scilit:
- Affinity selection‐mass spectrometry in the discovery of anti‐SARS‐CoV‐2 compoundsMass Spectrometry Reviews, 2022
- Evidence for antimicrobial activity in hemp hurds and lignin-containing nanofibrillated cellulose materialsCellulose, 2022
- Phytochemical characterization and biological properties of two standardized extracts from a non‐psychotropic Cannabis sativa L. cannabidiol (CBD)‐chemotypePhytotherapy Research, 2021
- Antivirals with common targets against highly pathogenic virusesCell, 2021
- Endocannabinoids Inhibit the Induction of Virulence in Enteric PathogensCell, 2020
- Isolation of nanocellulose from hemp (Cannabis sativa) fibers by chemo‐mechanical method and its characterizationPolymer Composites, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Systemic and Target-Site Pharmacokinetics of Antiparasitic AgentsClinical Pharmacokinetics, 2020
- High prevalence of cannabis use among Aka foragers of the Congo Basin and its possible relationship to helminthiasisAmerican Journal of Human Biology, 2015
- Cannabidiol – Recent AdvancesChemistry & Biodiversity, 2007